Valuation (83%) |
Company | Industry |
|---|---|---|
| P/E Ratio (TTM) | 11.41 | N/A |
| PEG Ratio (TTM) | -0.96 | N/A |
| P/S Ratio (TTM) | 0.11 | N/A |
| P/B Ratio (TTM) | 0.38 | N/A |
| P/FCF Ratio (TTM) | 11.22 | N/A |
| Price to 5YR AVG Earnings Ratio | 15.81 | N/A |
| Price to 5YR AVG FCF Ratio | 8.09 | N/A |
Profitability (20%) |
Company | Industry |
|---|---|---|
| ROA (TTM) | 1.58% | N/A |
| ROE (TTM) | 3.35% | N/A |
| Net Profit Margin (TTM) | 0.97% | N/A |
| ROIC 5YR AVG | 7.21% | N/A |
Growth (75%) |
4QTR AVG | 3YR AVG | 5YR AVG |
|---|---|---|---|
| EPS | 8.28% | 176.86% | 109.59% |
| Revenue | -1.40% | -3.28% | -2.26% |
| Net Income | 8.57% | 180.16% | 111.49% |
| Cash Flow | 91.30% | 31.38% | 20.98% |
Health (68%) |
Company | Industry |
|---|---|---|
| Current Ratio (TTM) | 1.61 | N/A |
| Quick Ratio (TTM) | 1.61 | N/A |
| D/E Ratio (TTM) | 0.18 | N/A |
| Interest Coverage (TTM) | 6.82 | N/A |
| Piotroski F-Score | 8 | N/A |
| Altman Z-Score | 2.78 | N/A |
| LTL to 5YR AVG FCF | 0.72 | N/A |
| Shares Outstanding Growth 5YR AVG | -1.51% | N/A |